Table of Content - Still’s Disease Treatment Market

Still's disease, also known as Adult-onset Still's Disease (AOSD), is a rare inflammatory disease characterized by joint pain, rash, and fever. This devastating condition can lead to long-term chronic arthritis and permanent injuries. Still's disease is associated with a rash that does not itch and a high fever. This disorder can destroy the affected joints, especially the wrists. Treatment for Still's disease includes anti-inflammatory medications. Still's disease is a rare rheumatic disease. This disease is characterized by biological and clinical symptoms such as high fever, joint swelling, myalgia, sore throat, increase in white blood cells (leukocytes, especially neutrophils), and biological hepatitis. Treatment for Still's disease can be divided into two categories, namely symptomatic treatments and effective treatments. Symptomatic treatment can be started immediately even if the diagnosis is not confirmed, while effective treatment methods are designed to treat the disease more effectively to eliminate the symptoms of the disease.

Market Dynamics

Increasing practices of treatments, mergers, and acquisitions by key market players are expected to drive the global Still’s disease treatment market growth. For instance, on April 13, 2023, Metropolis Healthcare noted that treatment of Still's disease with nonsteroidal anti-inflammatory drugs (NSAIDs), these medications reduce inflammatory pain and the signs and symptoms of Still’s disease. Corticosteroids reduce inflammation by reducing the activity of the immune system. Disease-modifying Antirheumatic Drugs (DMARDs) can help slow down the progress of Still’s disease and reduce the frequency of flares. Physical therapy, exercise, rest, and a healthy diet can help manage the condition and keep symptoms to a minimum.

Key features of the study:

This report provides an in-depth analysis of the global Still’s disease treatment market and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global Still’s disease treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
The key companies covered as a part of this study include AB2 Bio Ltd , F.offmann-La Roche Ltd, Novartis AG, Swedish Orphan Biovitrum AB, Jubilant Life Sciences Ltd, Vintage Labs, Hikma Pharmaceuticals PLC, Teva Pharmaceutical Industries Ltd, Mylan N.V, Horizon Therapeutics plc, Sun Pharmaceutical Industries Ltd, Zydus Cadila, Amneal Pharmaceuticals LLC, Dr Reddy's Laboratories Ltd, and Fresenius Kabi AG
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global Still’s disease treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Still’s disease treatment market

Detailed Segmentation:

Global Still’s Disease Treatment Market, By Treatment :
- Pain Management
- Corticosteroids
- Tocilizumab
- Canakinumab
- Others
Global Still’s Disease Treatment Market, By Route of Administration :
- Injectables
- Oral
Global Still’s Disease Treatment Market, By Distribution Channels :
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
Global Still’s Disease Treatment Market, By Region:
- North America
  - U.S.
  - Canada
- Latin America
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
- Europe
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
- Asia Pacific
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
- Middle East
  - GCC
  - Israel
  - Rest of Middle East
- Africa
  - South Africa
  - Central Africa
  - North Africa
Company Profiles
- AB2 Bio Ltd.
- F.Hoffmann-La Roche Ltd
- Novartis AG
- Swedish Orphan Biovitrum AB
- Jubilant Life Sciences Ltd
- Vintage Labs
- Hikma Pharmaceuticals PLC
- Teva Pharmaceutical Industries Ltd
- Mylan N.V
- Horizon Therapeutics plc
- Sun Pharmaceutical Industries Ltd
- Zydus Cadila
- Amneal Pharmaceuticals LLC
- Dr Reddy's Laboratories Ltd
- Fresenius Kabi AG

“*” marked represents similar segmentation in other categories in the respective section

Table of Contents

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snapshot, By Treatment
  - Market Snapshot, By Route of Administration
  - Market Snapshot, By Distribution Channel
  - Market Snapshot, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Market Opportunities
- Impact Analysis
- Recent Product Launches
- Epidemiology
- Merger, Acquisition, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis
Global Still’s Disease Treatment Market – COVID-19 Impact Analysis
- Economic Impact
- COVID-19 Epidemiology
- Impact on Supply and Demand
Global Still’s Disease Treatment Market, By Treatment, 2018–2030, (US$ Billion)
- Introduction
  - Market Share Analysis, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis,
  - Segment Trends
- Pain Management
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Billion)
- Corticosteroids
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Billion)
- Tocilizumab
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Billion)
- Canakinumab
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Billion)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Billion)
Global Still’s Disease Treatment Market, By Route of Administration, 2018–2030, (US$ Billion)
- Introduction
  - Market Share Analysis, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, 2018–2030
  - Segment Trends
- Injectables
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Billion)
- Oral
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Billion)
Global Still’s Disease Treatment Market, By Distribution Channel, 2018–2030, (US$ Billion)
- Introduction
  - Market Share Analysis, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, 2018–2030
  - Segment Trends
- Retail Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Billion)
- Hospital Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Billion)
- Online Pharmacies
  - Market Share Analysis, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, 2018–2030
  - Segment Trends
Global Still’s Disease Treatment Market, By Region, 2018–2030, (US$ Billion)
- Introduction
  - Market Share Analysis, By Region, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, For Region, 2018–2030
  - Regional Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2018 - 2030, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2030, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2018–2030, (US$ Billion)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2018-2030, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2018–2030, (US$ Billion)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2018-2030, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2030, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2018–2030, (US$ Billion)
    - U.K.
    - Germany
    - Italy
    - France
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2018-2030, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2030, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2018–2030, (US$ Billion)
    - China
    - India
    - Japan
    - ASEAN
    - Australia
    - South Korea
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2018-2030, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2030, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2018–2030, (US$ Billion)
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2018-2030, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2030, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2018–2030, (US$ Billion)
    - North Africa
    - Central Africa
    - South Africa
Competitive Landscape
- AB2 Bio Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- F.Hoffmann-La Roche Ltd
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Novartis AG
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Swedish Orphan Biovitrum AB
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Jubilant Life Sciences Ltd
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Vintage Labs
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Hikma Pharmaceuticals PLC
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Teva Pharmaceutical Industries Ltd
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Mylan N.V
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Horizon Therapeutics plc
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Sun Pharmaceutical Industries Ltd
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Zydus Cadila
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Amneal Pharmaceuticals LLC
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Dr Reddy's Laboratories Ltd
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Fresenius Kabi AG
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
Section
- Research Methodology
- About Us

*Browse 40 market data tables and 48 figures on “Global Still’s Disease Treatment Market”- Global forecast to 2030

View Our Licence Options

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail
Request Discount